These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21669381)

  • 1. Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire.
    Montejo AL; Correas-Lauffer J; Mauriño J; Villa G; Rebollo P; Díez T; Cordero L
    Value Health; 2011 Jun; 14(4):564-70. PubMed ID: 21669381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Spanish version of the Body Weight, Image and Self-Esteem Evaluation Questionnaire in patients with severe mental disorders.
    Al-Halabi S; Garcia-Portilla MP; Saiz PA; Fonseca E; Bobes-Bascaran MT; Galván G; Iglesias C; Arrojo M; Benabarre A; Goikolea JM; Sanchez E; Sarramea F; Bobes J
    Compr Psychiatry; 2012 Nov; 53(8):1237-42. PubMed ID: 22578984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with bipolar disorder--a comparison with schizophrenic patients and healthy controls.
    Latalova K; Prasko J; Diveky T; Kamaradova D; Velartova H
    Psychiatr Danub; 2011 Mar; 23(1):21-6. PubMed ID: 21448093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coping style of schizophrenic patients in recovery from acute psychotic state.
    Yagi G; Kinoshita F; Nakamura A; Koshiishi M; Kanba S
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):75-8. PubMed ID: 1679275
    [No Abstract]   [Full Text] [Related]  

  • 6. [The (new) definition of compliance].
    Arolt V
    Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 9. Bipolar disorder: quality of life and the impact of atypical antipsychotics.
    Vornik LA; Hirschfeld RM
    Am J Manag Care; 2005 Oct; 11(9 Suppl):S275-80. PubMed ID: 16232010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32).
    Vieta E; Sánchez-Moreno J; Bulbena A; Chamorro L; Ramos JL; Artal J; Pérez F; Oliveras MA; Valle J; Lahuerta J; Angst J;
    J Affect Disord; 2007 Aug; 101(1-3):43-55. PubMed ID: 17189651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of Hunperdal Richter in psychiatry].
    Magyar GI; Fadgyas I
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From neuroleptics toward antipsychotics: quality of life and schizophrenia].
    Lançon C
    Encephale; 2003 Sep; 29(Pt 2):S43-6. PubMed ID: 14710537
    [No Abstract]   [Full Text] [Related]  

  • 15. Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics.
    Kao YC; Liu YP; Chou MK; Cheng TH
    Compr Psychiatry; 2011; 52(2):171-80. PubMed ID: 21295224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders.
    Jónsdóttir H; Friis S; Horne R; Pettersen KI; Reikvam A; Andreassen OA
    Acta Psychiatr Scand; 2009 Jan; 119(1):78-84. PubMed ID: 18983630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder.
    Pomykacz B; Mao M; Weiss RD; Teter CJ
    Harv Rev Psychiatry; 2007; 15(5):259-63. PubMed ID: 17924260
    [No Abstract]   [Full Text] [Related]  

  • 19. [Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire].
    Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Barrera S; Morales MD;
    Neurologia; 2008 Apr; 23(3):157-67. PubMed ID: 18370335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.